SYPRINE Drug Patent Profile
✉ Email this page to a colleague
When do Syprine patents expire, and when can generic versions of Syprine launch?
Syprine is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in SYPRINE is trientine hydrochloride. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Syprine
A generic version of SYPRINE was approved as trientine hydrochloride by WATSON LABS TEVA on February 7th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SYPRINE?
- What are the global sales for SYPRINE?
- What is Average Wholesale Price for SYPRINE?
Summary for SYPRINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 150 |
| Clinical Trials: | 3 |
| Patent Applications: | 5,049 |
| Drug Prices: | Drug price information for SYPRINE |
| What excipients (inactive ingredients) are in SYPRINE? | SYPRINE excipients list |
| DailyMed Link: | SYPRINE at DailyMed |
Recent Clinical Trials for SYPRINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of British Columbia | N/A |
| Valeant Pharmaceuticals International, Inc. | N/A |
| Bausch Health Americas, Inc. | N/A |
Pharmacology for SYPRINE
| Drug Class | Metal Chelator |
| Mechanism of Action | Metal Chelating Activity |
US Patents and Regulatory Information for SYPRINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | SYPRINE | trientine hydrochloride | CAPSULE;ORAL | 019194-001 | Nov 8, 1985 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
